![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/04 | |
A61K 31/55 | |||
A61P 25/00 |
(11) | Number of the document | 2046386 |
(13) | Kind of document | T |
(96) | European patent application number | 07764967.1 |
Date of filing the European patent application | 2007-06-29 | |
(97) | Date of publication of the European application | 2009-04-15 |
(45) | Date of publication and mention of the grant of the patent | 2014-07-23 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2007/005806 |
Date | 2007-06-29 |
(87) | Number | WO 2008/000513 |
Date | 2008-01-03 |
(30) | Number | Date | Country code |
06013655 | 2006-06-30 | EP | |
06021469 | 2006-10-12 | EP | |
06021470 | 2006-10-12 | EP | |
06024241 | 2006-11-22 | EP |
(72) |
HEERS, Cara, DE
STÖHR, Thomas, DE
BEYREUTHER, Bettina, DE
|
(73) |
UCB Pharma GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
(54) | PEPTIDE COMPOUNDS FOR THE TREATMENT OF SKELETAL MUSCLE DISORDERS ASSOCIATED WITH ION CHANNEL DYSFUNCTION |
PEPTIDE COMPOUNDS FOR THE TREATMENT OF SKELETAL MUSCLE DISORDERS ASSOCIATED WITH ION CHANNEL DYSFUNCTION |